renal contusion, 18-24–18-25
renal laceration, 18-24
renal pelvis rupture, 18-25
testicular contusion/rupture, 18-26–18-27
ureteral injuries, 18-25
Gentamicin
for cutaneous/subcutaneous cellulitis, 4-6
for Ludwig angina, 4-10
for pediatric meningitis, 14-17
for pelvic inflammatory disease/tubo-ovarian abscess, 7-6
for plague, 4-21
for pneumonia, 14-21
German Measles. See Rubella
Giant cell arteritis. See Temporal arteritis
Giardia lamblia, 3-14, 3-15, 14-16
GI Decontamination, 16-1
Glasgow–Blatchford score, 3-10
Glasgow Coma Scale, 18-1
Globe rupture, 18-8
Glucagon, 14-26, 19-4
Glucose, for pediatric advanced life support, 19-1
Glucose replacement, for hypoglycemia, 9-11
Gonococcal septic arthritis, 12-8
Gout, 12-6–12-7
Graft versus host disease (GVHD), cutaneous, 8-16–8-17
Group A Streptococcus pharyngitis, 13-3
Guillain–Barré syndrome (GBS), 5-17
H
Haldol, for psychiatric patient, 15-1
Haloperidol, 19-4
Hand-foot-and-mouth disease, 14-28
Hand fractures, 18-31
HAS-BLED score, 1-49
HCTZ, 1-36
Headache, 5-4
brain tumor, 5-8
CNS infections
abscess, 5-7–5-8
encephalitis, 5-6–5-7
meningitis, 5-6–5-7
CSF disorders
low CSF, 5-8
pseudotumor cerebri, 5-8
extracranial
acute sinusitis, 5-9
temporal arteritis, 5-9
primary
cluster headache, 5-5
migraine, 5-4–5-5
tension headache, 5-5
trigeminal neuralgia, 5-8–5-9
vascular
hypertensive headache, 5-6
subarachnoid hemorrhage, 5-5–5-6
venous sinus thrombosis, 5-6
Head trauma, 18-2
canadian head CT imaging rule, 18-3
diffuse axonal injury, 18-5
epidural hematoma, 18-5
head injury classifications, 18-3
intracerebral/intraparenchymal hemorrhage, 18-3–18-4
postconcussive syndrome, 18-3
scalp laceration, 18-2
skull fractures, 18-2
subarachnoid hemorrhage, 18-4
subdural hematoma, 18-4–18-5
Hearing loss, 13-2
cerumen impaction/foreign body, 13-2
ruptured tympanic membrane, 13-2
Heart failure, structural causes of, 1-23
Heat cramps, 10-15
Heat exhaustion, 10-16
Heat rash, 10-15
Heat stroke, 10-16–10-17
Heat syncope, 10-15–10-16
Heavy metals overdose, 16-18, 16-19
Heliox, for asthma, 14-22
Hematuria, 6-10
Hemolytic disease, 14-7
Hemolytic-uremic syndrome (HUS), 11-6
Hemophilia, 11-7–11-8
Hemoptysis, 2-6–2-7
Hemorrhagic stroke, 5-14–5-15
Hemorrhoids, 3-12
Hemothorax, 18-18
Henoch–Schönlein purpura, 14-29–14-30
Heparin, for disseminated intravascular coagulation, 11-7
Heparin-induced thrombocytopenia (HIT), 11-5
Hep B immune globulin (HBIG), 10-6
Herbicides overdose, 16-17, 16-19
Hernia, 3-4
Herniated disc, 12-4
Herpes genitalis, 8-4–8-5
Herpes gingivostomatitis, 8-4–8-5
Herpes labialis, 8-4–8-5
Herpes simplex 1 and 2 (HHV-1 and HHV-2), 8-4–8-5
Herpes zoster, 8-6–8-7
High-altitude illness, 10-12
Hip dislocations, 18-30
Hip fractures, 18-29
Hip/pelvic trauma, 18-28
acetabular fractures, 18-29
hip dislocations, 18-30
hip fractures, 18-29
pelvic fractures, 18-28
vascular pelvic injuries, 18-29
Hirschsprung disease, 14-3–14-4
HIV/AIDS, 4-11–4-12
antiretroviral drugs reactions, 4-12
complications of, 4-12
opportunistic infection prophylaxis, 4-11
organ involvement of, 4-12
Household products overdose, 16-18, 16-19
Human bite, 10-2
Humerus fractures, 18-31
Hunt–Hess scale, for subarachnoid hemorrhage, 18-4
Hydralazine, 19-3
for hypertension, 1-36
for preeclampsia/eclampsia, 7-3
Hydrocarbons/volatiles overdose, 16-17, 16-18
Hydrocortisone, 1-41
for adrenal insufficiency, 9-17
for hypercalcemia, 9-9
for hypothermia, 10-14
for thyroid storm, 9-16
Hydrocortisone cream, 8-14
Hyperbaric oxygen
in CO poisoning, 10-9
for high-altitude illness, 10-12
Hyperbilirubinemia
conjugated, 14-8
unconjugated, 14-6
Hypercalcemia, 9-8–9-9
Hypercalcemic antidote, 9-9
Hyperemesis gravidarum, 3-9, 7-3
Hyperglycemic emergencies, 9-11–9-13
diabetic ketoacidosis, 9-12–9-13
hyperosmolar hyperglycemic state, 9-12–9-13
Hyperkalemia, 9-7–9-8
Hypermagnesemia, 9-10
Hypernatremia, 9-4–9-5
Hyperosmolar hyperglycemic state (HHS), 9-11–9-13
Hypertension, 1-35–1-36
differential for, 1-35
treatment, 1-35–1-36
Hypertensive emergency, 1-36
Hypertensive headache, 5-6
Hyperthermia, 10-14
external heat emergencies
heat cramps, 10-15
heat exhaustion, 10-16
heat rash, 10-15
heat stroke, 10-16–10-17
heat syncope, 10-15–10-16
internal heat emergencies
malignant hyperthermia, 10-17
neuroleptic malignant syndrome, 10-17
serotonin syndrome, 10-17–10-18
Hyperthyroidism, 9-14–9-16
Hypervolemic hypernatremia, 9-5
Hypervolemic hyponatremia, 9-4
Hyphema, 13-7, 18-9–18-10
Hypocalcemia, 9-8
Hypoglycemia, 9-10–9-11, 14-26
Hypoglycemics, 16-16–16-17
Hypokalemia, 9-5–9-6
Hypomagnesemia, 9-9–9-10
Hyponatremia, 9-3–9-4
Hypotension and shock, 1-37–1-38
differential for, 1-37
RUSH protocol, 1-37
treatment, 1-38
vasoactive agents and dosing, 1-38
Hypothermia, 10-13
classifications of, 10-13
frostbite, 10-14
rewarming strategies, 10-14
Hypothyroidism, 9-13–9-14
Hypovolemia, 1-34–1-35
Hypovolemic hypernatremia, 9-5
Hypovolemic hyponatremia, 9-4
Hypovolemic shock, 1-38–1-39
I
Ibutilide, 1-47, 19-3
for atrial fibrillation and atrial flutter, 1-48
ICU medications, 19-3–19-4
Idiopathic intracranial hypertension, 5-8
Immune thrombocytopenia, 11-5
Impetigo, 8-8, 14-28–14-29
Incarcerated hernia, 14-2–14-3
Infectious diarrhea, 3-14–3-15
Infectious mononucleosis, 4-10–4-11
Infectious tenosynovitis, 12-6
Inflammatory bowel disease, 3-8
Inner ear barotrauma, 10-10
Inotropes, for CHF and acute pulmonary edema, 1-23
Insecticides overdose, 16-17
Insulin, 19-4
for diabetic ketoacidosis, 14-25
for hyperkalemia, 9-7
Intertrigo, 8-10
Intimate-partner violence, 18-36–18-37
Intoxicated patient, approach to, 16-1–16-2
Intracerebral/intraparenchymal hemorrhage, 18-3–18-4
Intracranial abscess, 4-5
Intraosseous catheterization, 19-7
Intubation
for asthma, 14-22
indications for, 17-1
Intussusception, 14-2
Invasive ventilation, chronic obstructive pulmonary disease, 2-5
Iodine, for thyroid storm, 9-16
Ipratropium bromide
for asthma, 14-22
for chronic obstructive pulmonary disease, 2-5
Ipratropium, for asthma, 2-4
Iron overdose, 16-17, 16-18
Irritable bowel syndrome, 3-15
Ischemic stroke, 5-13–5-14
Ivermectin, for scabies, 4-15
IV hydration, for diabetic ketoacidosis, 14-25
IVIG
for Kawasaki disease, 14-29
for toxic shock syndrome, 4-7
J
Jaundice, 3-16–3-17, 14-6
ABO and Rh incompatibility, 14-7
acute liver failure, 3-17–3-18
breast-feeding jaundice, 14-7
breast milk jaundice, 14-7
cirrhosis, 3-17
conjugated hyperbilirubinemia, 14-8
hemolytic disease, 14-7
physiologic jaundice, 14-7
unconjugated hyperbilirubinemia in children, 14-6
Jefferson fracture, 18-12
Jellyfish stings, 10-5
Joint pain, 12-5
bursitis, 12-7
etiology, 12-5–12-6
gout, 12-6–12-7
infectious
gonococcal septic arthritis, 12-8
septic arthritis, 12-7–12-8
pseudogout, 12-7
tenosynovitis, 12-6
K
Kanavel signs, 12-6
Kaposi’s sarcoma, 8-15–8-16
Kawasaki disease, 14-29
Kayexalate, for hyperkalemia, 9-7
Keflex, for cutaneous/subcutaneous cellulitis, 4-6
Ketamine, 19-4
for conscious sedation, 19-3
Ketoconazole cream, 8-14
Knee injuries, 18-31
Koplik spots:, 8-2
L
Labetalol, 19-3
for aortic dissection, 1-26
for hypertension, 1-36
for hypertensive headache, 5-6
for preeclampsia/eclampsia, 7-3
Lambert–Eaton Myasthenic syndrome (LEMS), 5-16–5-17
Large bowel obstruction, 3-6
Laryngotracheobronchitis, 14-23–14-24. See Croup
Lasix, for CHF and acute pulmonary edema, 1-23
Lateral cord syndrome. See Brown-Sequard syndrome
Lateral epicondylitis, 12-5
Le Fort classification, maxillary fractures, 18-8
Legg–Calvé–Perthes disease, 14-10
Leg pain and swelling, 12-1
peripheral vascular disease
acute extremity arterial occlusion, 12-1
ankle-brachial indices (ABIs), measurement of, 12-2
claudication, 12-1
trauma
compartment syndrome, 12-2
Lemierre’s syndrome, 13-4
Levetiracetam, for hemorrhagic stroke, 5-15
Levofloxacin
for cutaneous/subcutaneous cellulitis, 4-6
for epididymitis/orchitis, 6-8
for perirectal abscesses, 4-5
for plague, 4-21
for sexually transmitted infection, 7-5
for spontaneous bacterial peritonitis, 3-7
Levothyroxine
for hypothermia, 10-14
for hypothyroidism, 9-14
Lichen tropicus. See Heat rash
Lid disorders, 13-8
Lidocaine, 19-3
for pediatric advanced life support, 19-1
for ventricular tachycardia, 1-51
Lightning injury, 10-18–10-19
Limp, 14-8–14-9
infectious
septic arthritis of hip, 14-9
toxic (transient) synovitis, 14-9–14-10
musculoskeletal
Legg–Calvé–Perthes disease, 14-10
Osgood–Schlatter disease, 14-11
slipped capital femoral epiphysis, 14-10–14-11
Lindane, for scabies, 4-15
Linezolid
for cutaneous abscess, 4-3
for cutaneous/subcutaneous cellulitis, 4-6
Lithium toxicity, 16-4–16-5
Liver failure, acute, 3-17–3-18
Liver laceration, 18-21
Lorazepam
for primary seizures, 14-12
for psychiatric patient, 15-1
for status epilepticus, 5-11
Lou Gehrig’s disease. See Amyotrophic lateral sclerosis
Lower back pain. See Back pain, lower
LRINEC score, 4-8
Lumbar nerve root compression, 12-4
Lumbar puncture, 19-7–19-8
Lumbar spinal stenosis, 12-3–12-4
Lyme disease, 4-16
Lysergic acid diethylamide (LSD), 16-10
M
Maalox, 3-10
Macrolide, for pneumonia, 14-21
Magnesium
for asthma, 14-22
for hypertension, 1-36
for hypomagnesemia, 9-10
for placenta previa and abruptio placentae, 7-2
for preeclampsia/eclampsia, 7-3
for ventricular tachycardia, 1-51
Magnesium sulfate, for pediatric advanced life support, 19-1
Malaria, 4-18
Malignant hyperthermia (MH), 10-17
Malignant (necrotizing) otitis externa, 13-1
Mallory–Weiss tear, 3-11
Malrotation with midgut volvulus, 14-2
Mandibular fractures, 18-7
Mannitol, 10-16, 14-25, 18-3, 18-4, 19-4
Marcaine, 18-34
Mastoiditis, 13-2
Maxillary fractures, 18-7–18-8
Maxillofacial injury, 18-6
mandibular fractures, 18-7
maxillary fractures, 18-7–18-8
nasal fractures, 18-6–18-7
septal/auricular hematomas, 18-6
soft tissue injury, 18-6
zygomatic fracture, 18-7
Measles, 8-2–8-3
Mechanical ventilation, 19-1
acute respiratory distress syndrome, 2-6
indications for, 19-1
invasive ventilation, 19-1–19-2
making changes to ventilator, 19-2
noninvasive ventilation, 19-1
ventilator settings, 19-2
Meckel’s diverticulum, 14-3
Meclizine, for peripheral vertigo, 5-3
Medial epicondylitis, 12-5
Meningitis, 5-6–5-7
pediatric, 14-17
Mental status, altered, 5-1
causes of, 5-1
coma, 5-1
delirium, 5-1
dementia, 5-2
physical examination in, 5-1
Mesenteric ischemia, 3-7
Metabolic acidosis, 9-1
Metabolic alkalosis, 9-2
Metamucil, 3-15
Methamphetamine, 16-10
Methemoglobinemia, 16-16
Methimazole, for thyroid storm, 9-15
Methotrexate, for miscarriage, 7-1
Methylenedioxymethamphetamine (MDMA), 16-10
Methylprednisolone, for chronic obstructive pulmonary disease, 2-5
Methylxanthine derivatives, 5-8
Metoclopramide, 14-15
for migraine, 5-5
Metoprolol
for atrial fibrillation and atrial flutter, 1-48
for hypertension, 1-36
Metronidazole
for appendicitis, 3-3
for cholangitis, 3-2
for intracranial abscess, 4-5
for Ludwig angina, 4-10
for perirectal abscesses, 4-5
for sexually transmitted infection, 7-5
Midazolam, 19-4
for analgesia & conscious sedation, 19-2
for primary seizures, 14-12
Middle ear barotrauma, 10-10
Migraine, 5-4–5-5
Miliaria. See Heat rash
Milrinone, 1-38
Miscarriage, 7-1–7-2
Mitral regurgitation (MR), 1-24
Modified Duke criteria, for endocarditis, 4-1–4-2
Molluscum contagiosum, 8-7
Morphine, 19-4
for analgesia & conscious sedation, 19-2
for aortic dissection, 1-26
for burns, 10-7
for CHF and acute pulmonary edema, 1-23
for pain in STEMI, 1-8
for pericarditis, 1-29
for UA/NSTEMI, 1-11
for urolithiasis, 6-9
Multiple sclerosis (MS), 5-17–5-18
Myasthenia gravis, 5-16
Mycosis fungoides, 8-15
Myocarditis, 1-30
Myxedema coma, 9-13–9-14
N
N-acetylcysteine (NAC), 16-11
Nafcillin
for cutaneous/subcutaneous cellulitis, 4-6
for mastoiditis, 13-2
for staphylococcus scalded skin syndrome, 4-7
for toxic shock syndrome, 4-7
Nail bed laceration, 18-35
Naloxone, 19-3, 19-4
for pediatric advanced life support, 19-1
Nasal fractures, 18-6–18-7
Nasal vasoconstrictor drops/spray, 10-10
Nasogastric intubation, 19-8
Nausea and vomiting, 3-8–3-9, 14-14–14-16
gastroenteritis, 3-9, 14-15–14-16
gastroesophageal reflux disease, 14-15
hyperemesis gravidarum, 3-9
pyloric stenosis, 14-14
Neck trauma, 18-10–18-11
penetrating, 18-11
strangulation, 18-11
trauma zones, penetrating, 18-11
Necrotizing enterocolitis (NEC), 14-3
Necrotizing fasciitis, 4-8
Neonatal complaints, 14-17
apparent life-threatening event, 14-18–14-19
constipation, 14-17–14-18
crying and colic, 14-18
poor feeding, 14-17
SIDS, 14-19
Nephrolithiasis, 6-8–6-9
Neurogenic shock, 1-41
Neuroleptic malignant syndrome (NMS), 10-17, 16-4
Neuroleptics, 16-4
Neutropenic fever, 11-2
Nicardipine, 19-3
Nifedipine
for high-altitude illness, 10-12
for urolithiasis, 6-9
NIH Stroke Scale, 5-12
Nimodipine, 18-4
for hemorrhagic stroke, 5-15
Nitrates
for CHF and acute pulmonary edema, 1-23
for STEMI, 1-9
for UA/NSTEMI, 1-11
Nitrofurantoin
for asymptomatic bacteriuria in pregnancy, 6-2
for recurrent urinary tract infection, 6-5
Nitrofurantoin monohydrate macrocrystals, 6-2
Nitrogen narcosis, 10-10
Nitroglycerin, 19-3
for hypertension, 1-36
Nitroprusside, 19-3
for aortic dissection, 1-26
for hypertension, 1-36
for hypertensive headache, 5-6
for preeclampsia/eclampsia, 7-3
Nitrous oxide, for conscious sedation, 19-3
Noninvasive ventilation
for asthma, 14-22
for chronic obstructive pulmonary disease, 2-5
Norepinephrine, 1-38, 19-3
for neurogenic shock, 1-41
Norwalk virus, 14-15
Novocaine, 18-34
NSAIDs
for acute lumbosacral strain, 12-3
for cholelithiasis, 3-1
for gout, 12-6
for migraine, 5-5
for pericarditis, 1-29
for tension headache, 5-5
for urolithiasis, 6-9
Nummular eczema, 8-12
O
Occupational exposure, 10-6
antiretrovirals for HIV exposure, 10-6
risk assessment, 10-6
Octreotide, 19-4
Odontoid fracture, 18-13
Odynophagia, 3-12
Ofloxacin, for epididymitis/orchitis, 6-8
Olanzapine, for psychiatric patient, 15-1
Oncologic emergencies
neutropenic fever, 11-2
tumor lysis syndrome, 11-2–11-3
Ondansetron, 14-15
Opiate analgesics, for cholelithiasis, 3-1
Opiates, 16-9
for acute lumbosacral strain, 12-3
for analgesia & conscious sedation, 19-2
Optic neuritis, 13-9
Orbital cellulitis, 13-7
Orbital fracture, 18-8
Orchitis, 6-7–6-8
Organophosphates overdose, 16-18
Orthodromic AVRT, 1-50
Orthopedic injuries, extremity, 18-30–18-31
Orthostatic hypotension, 1-34–1-35
Osgood–Schlatter disease, 14-11
Osmolar gap, 9-1
Otitis externa, 13-1
Otitis media, 13-1–13-2
Ovarian cyst, 7-5
Ovarian torsion, 7-5
Oxytocin
miscarriage, 7-1
for miscarriage, 7-1
P
Pacemaker (PM), 1-51
malfunction, 1-52
Palpitations, 1-44–1-51
Pancreatic injury, 18-23
Pancreatitis, 3-2–3-3
Pancuronium, 19-4
Paracentesis, 19-8–19-9
Paraphimosis, 6-14–6-15
Parasitic infections
scabies, 4-15
toxoplasmosis, 4-15
Paronychia, 4-3
Patellar tendonitis, 12-5
PDE-5 inhibitors, 10-12
Pediatric advanced life support (PALS), 19-1
Pediatric exanthems, 14-28–14-30
erysipelas, 14-28
hand-foot-and-mouth disease, 14-28
Henoch–Schönlein purpura, 14-29–14-30
impetigo, 14-28–14-29
Kawasaki disease, 14-29
serum sickness, 14-29
viral exanthem, 14-28
Pediatric fever, 14-4–14-6
evaluation of, by age, 14-6
febrile child 3–36 mo, 14-5–14-6
febrile infant 0–90 day old, 14-5
Pediatric meningitis, 14-17
Pediatric seizure, 14-11–14-14
cerebral palsy, 14-13
epilepsy, 14-12–14-13
febrile seizures, 14-13–14-14
primary seizures, 14-12
seizure types, 14-13
Pelvic fractures, 18-28
Pelvic inflammatory disease, 3-4–3-5, 7-6
Pelvic pain, female, 7-4–7-5
ovarian cyst, 7-5
ovarian torsion, 7-5
Penicillin G, for erysipelas, 14-28
Penile amputation/laceration, 18-27
Penile fracture, 18-27
Peptic ulcer disease (PUD), 3-10
Perforated viscous, 3-6–3-7
Pericardiocentesis, 19-9
Pericarditis and pericardial effusion, 1-27–1-29
ECG changes in pericarditis, 1-28
pulsus paradoxus test, 1-28
treatment, 1-29
Peripheral vascular disease, 12-1–2-2
Perirectal abscess, 4-4–4-5
Peritonitis, 6-17
Permethrin, for scabies, 4-15
Pertussis, 13-4
Phenobarbital, 19-4
for preeclampsia/eclampsia, 7-3
for primary seizures, 14-12
for seizures, 5-11
for status epilepticus, 5-11
Phenoxybenzamine, for hypertension, 1-36
Phentolamine, for hypertension, 1-36
Phenylephrine, 1-38, 19-3
for neurogenic shock, 1-41
Phenylephrine injection, for priapism, 6-15
Phenytoin, 19-4
for primary seizures, 14-12
for seizures, 5-11
for status epilepticus, 5-11
Phenytoin/fosphenytoin overdose, 16-17, 16-18
Phimosis, 6-14–6-15
Physiologic jaundice, 14-7
Physostigmine, 16-3
Pilonidal cyst, 4-3
Pink puffer, 2-5
Piperacillin/tazobactam
for appendicitis, 3-3
for bacterial prostatitis, 6-7
for cholangitis, 3-2
for necrotizing fasciitis, 4-8
Pit viper envenomation, 10-3
Pityriasis rosea, 8-7
Pivmecillinam, for acute cystitis, 6-2
Placenta previa, 7-2
Plague, 4-21
Platelet disorders and coagulopathy, 11-4
coagulopathy, 11-7
disseminated intravascular coagulation, 11-7
hemolytic-uremic syndrome, 11-6
hemophilia, 11-7–11-8
heparin-induced thrombocytopenia, 11-5
immune thrombocytopenia, 11-5
platelet dysfunction, 11-4
thrombocytopenia, 11-4
thrombotic thrombocytopenic purpura, 11-6
von Willebrand’s disease, 11-6
Platelet dysfunction, 11-4
Pneumomediastinum, 10-10
Pneumonia, 2-1–2-2, 14-21
pneumonia severity index, 2-2
treatment, 2-1
Pneumothorax, 18-17–18-18
Pompholyx. See Dyshidrotic eczema
PORT score, 2-2
Postcoital bleeding, 7-3
Postconcussive syndrome, 18-3
Post-MI complications, 1-16
Dressler syndrome, 1-16
IMI complications
heart block, 1-16
precordial ST, 1-16
RV infarct, 1-16
LV failure, 1-16
LV thrombus, 1-16
mechanical complications
arrhythmias, 1-16
free wall rupture, 1-16
papillary muscle rupture, 1-16
pericarditis, 1-16
ventricular aneurysm, 1-16
Post-PCI complications, 1-15–1-16
AV fistula, 1-15
bleeding, 1-15
renal failure, 1-15
stent stenosis, 1-16
stent thrombosis, 1-16
vascular damage, 1-15
Potassium replacement, 9-6
Prasugrel
for primary PCI, 1-10
for UA/NSTEMI, 1-12
Prednisone
for asthma, 2-4
for Bell’s palsy, 5-4
for chronic obstructive pulmonary disease, 2-5
for cluster, 5-5
for idiopathic intracranial hypertension, 5-8
for immune thrombocytopenia, 11-5
for temporal arteritis, 5-9, 13-9
Preeclampsia, 7-3
Pre-excitation, 1-50
Priapism, 6-15–6-16
definition of, 6-15
ischemic, 6-15
nonischemia, 6-15
treatment, 6-15–6-16
Prickly heat. See Heat rash
Primary PCI, 1-10
vs. fibrinolysis, 1-8
Primary survey, 18-1
Prinzmetal’s angina, 1-12–1-13
Procainamide, 1-47, 19-3
for atrial fibrillation and atrial flutter, 1-48
Procedures, 19-5
arterial puncture and catheterization, 19-5–19-6
central venous catheterization, 19-6–19-7
incision and drainage, 19-7
intraosseous catheterization, 19-7
lumbar puncture, 19-7–19-8
nasogastric intubation, 19-8
paracentesis, 19-8–19-9
pericardiocentesis, 19-9
thoracentesis, 19-9
tube thoracostomy, 19-10
Prochlorperazine, for migraine, 5-5
Proctalgia. See Rectal pain
Promethazine, for peripheral vertigo, 5-3
Propafenone, for atrial fibrillation and atrial flutter, 1-48
Propofol, 19-4
for conscious sedation, 19-3
Propranolol, 19-3
for atrial fibrillation and atrial flutter, 1-48
Proton pump inhibitor, for peptic ulcer disease/gastritis, 3-10
Pseudogout, 12-7
Pseudotumor cerebri, 5-8
Psoriasis, 8-10–8-11
Psychiatric patient, 15-1
PTU, for thyroid storm, 9-15
Pulmonary contusion, 18-19
Pulmonary embolism (PE) and deep vein thrombosis (DVT), 1-16–1-17
D-dimer testing
clinical probability of DVT after, 1-19
posttest probability of PE after, 1-18
evaluation
deep vein thrombosis, 1-18–1-19
pulmonary embolism, 1-18
high pretest probability of DVT, 1-20
low pretest probability of DVT, 1-19
moderate pretest probability of DVT, 1-20
PERC criteria, 1-17
simplified revised Geneva score, 1-17
treatment, 1-21
Wells criteria
for DVT, 1-19
for PE, 1-17
Pulmonary HTN, 1-33
Pyloric stenosis, 14-14
Pyridostigmine, for myasthenia gravis, 5-16
Pyrimethamine, for toxoplasmosis, 4-15
Q
Quinine, for babesiosis, 4-18
R
Rabies
encephalitis, 4-12–4-13
postexposure prophylaxis, 4-13–4-14
Ramsay Hunt syndrome, 8-6
Ranitidine, 14-15
Ranson criteria, pancreatitis, 3-3
Rasburicase, 11-3
Rash, 8-1
allergic/inflammatory exanthems
eczema, 8-12 (See also Eczema)
erythema nodosum, 8-11
psoriasis, 8-10–8-11
urticaria, 8-11–8-12
bacterial exanthems
impetigo, 8-8
scarlet fever, 8-7–8-8
differential, 8-2
fungal exathems
cutaneous candidiasis and intertrigo, 8-10
dermatophytoses, 8-9
tinea (pityriasis) versicolor, 8-10
history, 8-1
morphologies, 8-1
neoplastic/other exanthems
cutaneous graft versus host disease (GVHD), 8-16–8-17
Kaposi’s sarcoma, 8-15–8-16
mycosis fungoides, 8-15
Sézary syndrome, 8-15
viral exanthems
erythema infectiosum, 8-3–8-4
herpes simplex 1 and 2 (HHV-1 and HHV-2), 8-4–8-5
herpes zoster, 8-6–8-7
measles, 8-2–8-3
molluscum contagiosum, 8-7
pityriasis rosea, 8-7
roseola infantum, 8-4
rubella, 8-3
varicella, 8-5–8-6
Raxibacumab injection, 4-21
Rectal pain, 3-18
Renal contusion, 18-24–18-25
Renal failure, acute, 6-11–6-13
Renal laceration, 18-24
Renal pelvis rupture, 18-25
Renal replacement therapy, 1-41, 6-13
Respiratory acidosis, 9-2
Respiratory alkalosis, 9-2
Respiratory complaints, pediatric, 14-21
asthma, 14-21–14-22
bacterial tracheitis, 14-24–14-25
bronchiolitis, 14-21–14-22
bronchopulmonary dysplasia, 14-22–14-23
epiglottitis, 14-24
foreign body/upper airway obstruction, 14-23–14-24
pneumonia, 14-21
upper airway emergencies, 14-23
Retained products of conception, 7-2
Retinal detachment, 13-9, 18-9
Retrobulbar hematoma, 13-6, 18-9
Reversal agents, 11-9, 19-3
Reynold’s pentad, 3-2
Rhabdomyolysis, 18-33
Rh immunoglobulin, 7-1, 7-2
Rickettsia Rickettsii, 4-17
Rifampin, for cutaneous/subcutaneous cellulitis, 4-6
Risperidone, for psychiatric patient, 15-1
Rivaroxaban, 1-49
Rocky mountain spotted fever, 4-17
Rocuronium, 19-4
Rodenticides overdose, 16-18, 16-19
Roseola infantum, 8-4
Rotator cuff injury, 12-5
Rotavirus, 14-15
Rubella, 8-3
Rubeola. See Measles
RUSH protocol, 1-37
S
Sacral fracture, 18-15
Salicylate poisoning, 16-12
Salmonella, 3-14, 14-16
SA node block, 1-42
S. aureus, 14-16
Scabies, 4-15
Scalp laceration, 18-2
Scarlatina. See Scarlet fever
Scarlet fever, 8-7–8-8
Scleral penetration, 13-6
Scorpion bites, 10-4
Seborrheic dermatitis, 8-13–8-14
Second disease. See Scarlet fever
Seizure, pediatric, 14-11–14-14
Seizures, 5-9–5-10
clues for true neurogenic seizure, 5-10
etiologies, 5-10
primary, 5-10–5-11
status epilepticus, 5-11
types of, 5-10
Selective serotonin reuptake inhibitors (SSRI), 16-3–16-4
Selenium sulfide lotion, 8-10
Selenium sulfide shampoo, 8-14
Sepsis. See Septic shock
Sepsis, postabortion, 7-2
Septal hematomas, 18-6
Septic arthritis, 12-7–12-8
of hip, 14-9
Septic shock, 1-39–1-41
causes of, 1-40
diagnostic criteria for sepsis, 1-40
treatment of, 1-40–1-41
Serotonin reuptake inhibitors (SRIs), 16-3
Serotonin syndrome (SS), 10-17–10-18, 16-3–16-4
Serum sickness, 14-29
Sexual assault, 18-36
Sexually transmitted infection, 7-5
Sézary syndrome, 8-15
Shigella, 3-14, 14-16
Shingles. See Herpes zoster
Shock, 14-1
cardiogenic, 1-39
hypovolemic, 1-38–1-39
neurogenic, 1-41
septic, 1-39–1-41
Shortness of breath. See Dyspnea
Shoulder dislocations, 18-31
SIADH, 9-4
Sickle cell disease, 11-3–11-4
Sick sinus syndrome, 1-42–1-43
SIDS, 14-19
Silvadene, 10-7
Sinus bradycardia, 1-42
Sinusitis, 13-4–13-5
Sinusitis, acute, 5-9
SIRS. See Septic shock
Sixth Disease. See Roseola infantum
Skin hydration, 8-12
Skull fractures, 18-2
Slipped capital femoral epiphysis (SCFE), 14-10–14-11
Small bowel injury, 18-22
Small bowel obstruction, 3-6
Small pox, 4-22
Snake bites, 10-3
elapidae/coral snake, 10-3–10-4
pit vipers, 10-3
Sodium bicarbonate, 16-5
for TCA overdose, 16-5
Sodium polystyrene sulfonate (Kayexalate), 16-5
Soft tissue infections, 4-5–4-6
dermatologic
cutaneous cellulitis, 4-6
erysipelas, 4-6–4-7
necrotizing fasciitis, 4-8
staphylococcus scalded skin syndrome, 4-7
subcutaneous cellulitis, 4-6
toxic shock syndrome, 4-7–4-8
genitourinary
Fournier gangrene, 4-8–4-9
ophthamologic
orbital cellulitis, 4-9–4-10
periorbital cellulitis, 4-9
preseptal cellulitis, 4-9
otolarngologic
Ludwig angina, 4-10
Sore throat, 13-3
croup, 13-3–13-4
epiglottitis, 13-4
group A Streptococcus pharyngitis, 13-3
Lemierre’s syndrome, 13-4
pertussis, 13-4
Spider bites
black widow, 10-4–10-5
brown recluse, 10-4
Spinal epidural abscess, 12-4
Spinal shock, 18-16
Spine trauma, 18-14
anterior cord syndrome, 18-15
anterior wedge/compression fracture, 18-14
Brown-Sequard syndrome, 18-16
burst fracture, 18-14
central cord syndrome, 18-15–18-16
chance fracture, 18-15
sacral fracture, 18-15
spinal shock, 18-16
Spiramycin, for toxoplasmosis, 4-15
Splenic laceration, 18-21–18-22
Spontaneous bacterial peritonitis, 3-7–3-8
Staphylococcus aureus, 3-14
Staphylococcus scalded skin syndrome, 4-7
Status epilepticus, 5-11
STEMI, 1-8–1-10
Stenosing flexor tenosynovitis, 12-6
Stephens-Johnson syndrome (SJS), 8-18
Steroid preparations, topical, by Stoughton–Cornell classification of potency, 8-14–8-15
Steroids
for adrenal insufficiency, 9-17
for asthma, 2-4, 14-22
for chronic obstructive pulmonary disease, 2-5
for croup, 14-24
for gout, 12-6
for immune thrombocytopenia, 11-5
for pericarditis, 1-29
for thyroid storm, 9-16
for toxic shock syndrome, 4-7
for transverse myelitis, 5-18
for urticaria, 8-12
Strangulated hernia, 14-2–14-3
Strangulation, 18-11
Strep Throat. See Group A Streptococcus pharyngitis
Streptomycin
for plague, 4-21
Stress testing, 1-14–1-15
Stroke, 5-11–5-15
ABCD2 score, 5-13
hemorrhagic, 5-14–5-15
ischemic, 5-13–5-14
NIH Stroke Scale, 5-12
patterns, 5-15
thrombolysis in, criteria for, 5-14
transient ischemic attack, 5-13
Subarachnoid hemorrhage (SAH), 5-5–5-6, 18-4
Subclavian steal, 1-33–1-34
Subconjunctival hemorrhage, 18-10
Subcutaneous cellulitis, 4-6
Subdural hematoma (SDH), 18-4–18-5
Subluxation/ligamentous injury, 18-14
Succinylcholine, 19-4
Sulfadiazine, for toxoplasmosis, 4-15
Sumatriptan
for cluster, 5-5
for migraine, 5-5
Supplemental oxygen, for chronic obstructive pulmonary disease, 2-5
Supraventricular tachycardia, 1-44–1-45
diagnosis, 1-45
pathophysiologies, 1-45
treatment, 1-45
Swimmer’s ear. See Otitis externa
Syncope, 1-30–1-33
Boston syncope criteria, 1-32–1-33
differential for, 1-30
ECG findings, 1-31
evaluation of, 1-32
OESIL score, 1-32
San Francisco syncope rule, 1-32
T
Tachy–brady syndrome, 1-42–1-43
Tachycardia, 1-44–1-51
Tacrolimus, for cutaneous graft versus host disease, 8-17
Tamsulosin, for urolithiasis, 6-9
Tear drop fracture, 18-13
Temporal arteritis, 5-9, 13-9
Tenosynovitis, 12-6
Tension headache, 5-5
Terazosin, for urolithiasis, 6-9
Terbutaline
for asthma, 14-22
for priapism, 6-15
Testicular contusion/rupture, 18-26–18-27
Testicular torsion, 6-14
Tetanus, 4-14
Tetanus prophylaxis, 10-7
Tetracycline
for cutaneous abscess, 4-3
for cutaneous/subcutaneous cellulitis, 4-6
Tetralogy of fallot, 14-20
Thiopental, 19-4
Third disease. See Rubella
Thoracentesis, 19-9
Thoracic aortic aneurysm, 1-26–1-27
Thoracic trauma, 18-16–18-17
cardiac contusion, 18-19
cardiac tamponade, 18-19
esophageal injury, 18-20
flail chest, 18-18
hemothorax, 18-18
pneumothorax, 18-17–18-18
pulmonary contusion, 18-19
tracheobronchial tear, 18-20
traumatic aortic rupture, 18-17
Three-day measles. See Rubella
Thrombocytopenia (TCP), 11-4
Thrombolysis in stroke, criteria for, 5-14
Thrombotic thrombocytopenic purpura (TTP), 11-6
Thyroid emergencies, 9-13–9-16
hyperthyroidism, 9-14–9-16
hypothyroidism, 9-13–9-14
myxedema coma, 9-13–9-14
thyroid storm, 9-14–9-16
thyrotoxicosis, 9-14–9-16
Thyroid replacement, 9-14
Thyroid storm, 9-14–9-16
Thyrotoxicosis, 9-14–9-16
Tibia fractures, 18-31
Ticagrelor
for primary PCI, 1-10
for UA/NSTEMI, 1-12
Ticarcillin/clavulanate, for cholangitis, 3-2
Ticlopidine, for ischemic stroke, 5-13
Tirofiban
for primary PCI, 1-10
for UA/NSTEMI, 1-12
TMP–SMX, for acute sinusitis, 5-9
Toothache, 13-10
acute necrotizing ulcerative gingivitis, 13-10–13-11
alveolar osteitis, 13-11
dental caries, 13-10
dental fractures, 13-10
periapical abscess, 13-10
tooth subluxation and avulsion, 13-10
Tooth subluxation and avulsion, 13-10
Topical azoles, for sexually transmitted infection, 7-5
Topical steroid preparations, by Stoughton–Cornell classification of potency, 8-14–8-15
Torsion of appendix, 6-14
Toxic epidermal necrolysis (TEN), 8-18–8-19
Toxicology treatments, 16-1–16-2
Toxic shock syndrome (TSS), 4-7–4-8
Toxic (transient) synovitis, 14-9–14-10
Toxoplasmosis, 4-15
Tracheobronchial tear, 18-20
Transfusion, 11-8
complications, 11-9
cryoprecipitate, 11-9
fresh frozen plasma, 11-8–11-9
packed red blood cell, 11-8
platelet, 11-8
Transfusion-associated circulatory overload (TACO), 11-9
Transfusion-related ALI (TRALI), 11-9
Transient ischemic attack, 5-13
Transplant patient, approach to, 11-10
Transverse myelitis, 5-18
Traumatic rupture of aorta, 18-17
Trench mouth. See Acute necrotizing ulcerative gingivitis
Tricyclic antidepressants (TCA)
for multiple sclerosis, 5-18
overdose, 16-5–16-6
Trimethoprim–sulfamethoxazole
for acute cystitis, 6-2
for acute uncomplicated pyelonephritis, 6-3
for bacterial prostatitis, 6-7
for recurrent urinary tract infection, 6-5
Triptans, for migraine, 5-5
Trochanteric bursitis, 12-5
Tube thoracostomy, 19-10
Tuboovarian abscess, 3-4–3-5, 7-6
Tumor lysis syndrome, 11-2–11-3
Tympanic membrane, rupture of, 13-2
U
UA/NSTEMI, 1-10–1-12
anticoagulant therapy, 1-12
antiplatelet therapy, 1-11–1-12
conservative vs. early invasive strategy, 1-11
routine medical therapies, 1-11
TIMI Risk Score for, 1-11
UFH
for primary PCI, 1-10
for UA/NSTEMI, 1-12
Ulcerative colitis (UC), 3-8
Unasyn
for Fournier gangrene, 4-9
for human bite, 10-2
for Ludwig angina, 4-10
for orbital cellulitis, 4-10
for periorbital/preseptal cellulitis, 4-9
Ureteral injuries, 18-25
Ureterolithiasis, 6-8–6-9
Urethral injuries
female, 18-26
male, 18-26
Urethritis, 6-5–6-6
Urinary anion gap, 9-1
Urinary tract infections (UTIs), 6-1, 14-30
asymptomatic bacteriuria, 6-2
catheter-associated, 6-4–6-5
classification, 6-1
complicated, 6-3–6-4
male urogenital tract infections
acute bacterial prostatitis, 6-6–6-7
epididymitis, 6-7–6-8
orchitis, 6-7–6-8
recurrent, 6-5
uncomplicated, 6-2–6-3
uncomplicated pyelonephritis, 6-3
urethritis, 6-5–6-6
Urolithiasis, 6-8–6-9
Urticaria, 8-11–8-12
V
Vaginal bleeding, 7-1
abruptio placentae, 7-2
ectopic pregnancy, 7-2
miscarriage, 7-1–7-2
placenta previa, 7-2
postabortion sepsis, 7-2
postcoital bleeding, 7-3
retained products of conception, 7-2
Vaginal discharge, 7-5
Valacyclovir, for herpes genitalis, 8-5
Valvular heart disease, 1-24
Vancomycin
for cutaneous abscess, 4-3
for cutaneous/subcutaneous cellulitis, 4-6
for Fournier gangrene, 4-9
for intracranial abscess, 4-5
for Ludwig angina, 4-10
for necrotizing fasciitis, 4-8
for orbital cellulitis, 4-10
for pediatric meningitis, 14-17
for pneumonia, 14-21
for septic arthritis, 12-8
for spontaneous bacterial peritonitis, 3-7
for staphylococcus scalded skin syndrome, 4-7
for toxic shock syndrome, 4-7
Variceal bleeds, 3-10–3-11
Varicella, 8-5–8-6
Varicella vaccine, 8-6
Varicella zoster immune globulin, 8-6
Variola, 4-22
Vascular access hemorrhage, 6-17
Vascular injury, extremity, 18-30
Vascular pelvic injuries, 18-29
Vascular trauma, 18-23
Vasoactive agents, 1-38
Vasopressin, 1-38, 19-3
Vasovagal, 1-34
V. Cholerae, 14-16
Vector-borne infections, 4-16
mosquito-borne diseases
dengue fever, 4-19
eastern equine encephalitis, 4-20
malaria, 4-18
West Nile disease, 4-19–4-20
yellow fever, 4-18–4-19
tick-borne diseases
babesiosis, 4-17–4-18
ehrlichiosis, 4-17
Lyme disease, 4-16
rocky mountain spotted fever, 4-17
Vecuronium, 19-4
Venous sinus thrombosis, 5-6
Ventricular tachycardia, 1-50–1-51
Verapamil, 19-3
for atrial fibrillation and atrial flutter, 1-48
Vertebral compression fracture, 12-3
Vertebrobasilar insufficiency, 1-34
Vertigo, 5-2–5-3
central, 5-3
vs. peripheral, 5-2
peripheral, 5-3
Vibrio parahaemolyticus, 3-15, 14-16
Viral exanthem, 14-28
for erysipelas, 14-28
Viral hepatitis, 3-16–3-17
Viral infections, 4-10
HIV/AIDS, 4-11–4-12
infectious mononucleosis, 4-10–4-11
Vision change and vision loss, 13-8
central retinal artery occlusion, 13-8–13-9
central retinal vein occlusion, 13-9
optic neuritis, 13-9
retinal detachment, 13-9
temporal arteritis, 13-9
Vitamin K
for coumadin toxicity, 16-2
for reversal, 11-9
Vitreous hemorrhage, 18-10
Volvulus, 3-6
Von Willebrand’s disease (vWD), 11-6
W
Warfarin, 1-49
for ischemic stroke, 5-13
Wasp sting, 10-4
Weakness/Fatigue, 5-15–5-16
focal weakness
multiple sclerosis, 5-17–5-18
transverse myelitis, 5-18
generalized weakness
amyotrophic lateral sclerosis, 5-17
Guillain–Barré syndrome, 5-17
Lambert–Eaton Myasthenic syndrome, 5-16–5-17
myasthenia gravis, 5-16
Westley Score, 13-3
West Nile disease, 4-19–4-20
Whole bowel irrigation, 16-1
Whooping cough. See Pertussis
Wolff–Parkinson–White, 1-50
Wound management, 18-33–18-34
fingertip wounds, 18-36
foreign body, 18-35
laceration, 18-34
Wrist fractures, 18-31
X
Xylocaine, 18-34
Y
Yellow fever, 4-18–4-19
Yersinia enterocolitica, 14-16
Yersinia Pestis, 4-21
Z
Zinc pyrithione shampoo, 8-14
Zinc supplementation, 14-15
Ziprasidone, for psychiatric patient, 15-1
Zosyn, for Fournier gangrene, 4-9
Zygomatic fracture, 18-7